News Overview

Indian benchmark indices reversed previous session gains on July 10, with Nifty closing below 24,350.

The allotment of shares was finalised on July 8, and Emcure Pharma shares were scheduled to be listed on the BSE and NSE on July 10.

It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.

The company's revenue from operations decreased by 30.3% to ₹180.7 Crore, down from ₹259.3 Crore in the previous fiscal year.

The license, which is still being reviewed by the finance ministry, will remove the biggest impediment to the entity.

The extension of infrastructure will make EV fast-charging more comfortable and accessible, allowing EV users to plan hassle-free long-distance trips.

The pressure from these major stocks pulled the benchmarks further down, reflecting investor concerns and market volatility.

India's vehicle retail sales increased by only 0.73% year on year in June, owing to delayed monsoons in several parts of the nation.

CPPIB owned a 5.96% interest in Delhivery. On April 25, it reduced its shareholding in Delhivery by 2.77% through block trades.

iDATA's audited consolidated financials show revenues of ~ ₹246 Crore and EBITDA of ~ ₹144 Crore in CY2023.